Össur Hf: Össur's total share capital

Össur Hf: Össur's total share capital

ID: 539129

(Thomson Reuters ONE) -


Announcement from Össur hf. no. 34/2017
Reykjavik, 28 April 2017
According to Article 84 of the Icelandic Act on Securities Transactions No.
108/2007, an issuer shall publish information on its total share capital on the
last trading day of the month when the share capital has been decreased.

Össur's total share capital is ISK 437,162,725 nominal value divided into the
same number of shares with a nominal value of ISK 1 each following the share
capital decrease in April 2017. For further information, see the Company's
announcement no. 29/2017 published on 11 April 2017.

Össur press releases by e-mail

If you wish to receive Össur press releases by e-mail please register at the
following web-site: http://www.ossur.com/investormailings

About Össur

Össur (NASDAQ: OSSR) is a global leader in non-invasive orthopaedics that help
people live a life without limitations. Its business is focused on improving
people's mobility through the delivery of innovative technologies within the
fields of braces, supports and prosthetic limbs. A recognized "Technology
Pioneer", Össur invests significantly in research and product development; its
award-winning designs ensuring a consistently strong position in
the market.  Successful patient and clinical outcomes are further empowered via
Össur's educational programs and business solutions.  Headquartered in Iceland,
Össur has major operations in the Americas, Europe and Asia, with additional
distributors worldwide. www.ossur.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Ossur Hf via GlobeNewswire








Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Invivoscribe® Receives FDA Approval for the LeukoStrat® CDx FLT3 Mutation Assay Companion Diagnostic Test for the Selection of Patients for Rydapt® and is the First Companion Diagnostic for AML Sequa Petroleum N.V. Extended Period To Publish 2016 Annual Report
Bereitgestellt von Benutzer: hugin
Datum: 28.04.2017 - 18:00 Uhr
Sprache: Deutsch
News-ID 539129
Anzahl Zeichen: 2069

contact information:
Town:

Reykjavik



Kategorie:

Business News



Diese Pressemitteilung wurde bisher 203 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Össur Hf: Össur's total share capital"
steht unter der journalistisch-redaktionellen Verantwortung von

Ossur Hf (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Ossur Hf



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z